4.6 Review

DUXAP8: A Promising lncRNA with Carcinogenic Potential in Cancer

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p

Yi Liu et al.

Summary: Our study revealed that DUXAP8 promotes tumor progression in LUAD by targeting miR-26b-5p. This provides a novel therapeutic target for the diagnosis and therapy of LUAD.

BIOSCIENCE REPORTS (2021)

Review Pathology

Current and future molecular diagnostics of gastric cancer

Rachel Sin-Yu Choi et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)

Article Pediatrics

The association between lncRNA LINC01296 and the clinical characteristics in neuroblastoma

Jing Wang et al.

JOURNAL OF PEDIATRIC SURGERY (2019)

Article Cell Biology

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

Christopher J. Ricketts et al.

CELL REPORTS (2018)

Review Biotechnology & Applied Microbiology

LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis

Jing Quan et al.

ONCOTARGETS AND THERAPY (2018)

Article Medicine, Research & Experimental

Long Non-Coding RNA DUXAP8 Enhances Renal Cell Carcinoma Progression via Downregulating miR-126

Tao Huang et al.

MEDICAL SCIENCE MONITOR (2018)

Review Biochemistry & Molecular Biology

LncRNA-mediated regulation of cell signaling in cancer

W-X Peng et al.

ONCOGENE (2017)